Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
CytomX Therapeutics
CTMX
$730M
| $4.66M | ﹤0.01% |
560,450
+1,730
| +0.3% | +$11.7K |
|
2627
Willdan Group
WLDN
$1.29B
| $4.65M | ﹤0.01% |
146,233
+1,479
| +1% | +$46.9K |
|
|
MNRL
2628
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $4.65M | ﹤0.01% |
216,742
+9,522
| +5% | +$185K |
|
|
CPRX
2629
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.63M | ﹤0.01% |
1,235,921
+45,009
| +4% | +$210K |
|
|
WAAS
2630
DELISTED
AquaVenture Holdings Limited
WAAS
| $4.63M | ﹤0.01% |
170,566
-978
| -0.6% | -$20.7K |
|
2631
Future Fuel
FF
$249M
| $4.62M | ﹤0.01% |
372,814
-2,157
| -0.6% | -$25.7K |
|
|
ANH
2632
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $4.6M | ﹤0.01% |
1,307,688
-2,778
| -0.2% | -$9.61K |
|
2633
iShares Currency Hedged MSCI Emerging Markets
HEEM
$293M
| $4.6M | ﹤0.01% |
173,693
+625
| +0.4% | +$16.1K |
|
2634
Bloom Energy
BE
$69.6B
| $4.58M | ﹤0.01% |
613,534
+4,334
| +0.7% | +$21K |
|
2635
Rigel Pharmaceuticals
RIGL
$762M
| $4.58M | ﹤0.01% |
214,138
+5,382
| +3% | +$111K |
|
|
LTM
2636
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $4.58M | ﹤0.01% |
450,688
-6,658
| -1% | -$74.4K |
|
2637
Energy Recovery
ERII
$399M
| $4.58M | ﹤0.01% |
467,427
-54,941
| -11% | -$506K |
|
|
CNBKA
2638
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $4.57M | ﹤0.01% |
50,793
-965
| -2% | -$84.3K |
|
|
CTO
2639
CTO Realty Growth
CTO
$823M
| $4.56M | ﹤0.01% |
278,787
-9,184
| -3% | -$159K |
|
|
EEX
2640
DELISTED
Emerald Holding
EEX
| $4.56M | ﹤0.01% |
432,445
+12,791
| +3% | +$127K |
|
2641
KRONOS Worldwide
KRO
$996M
| $4.56M | ﹤0.01% |
339,985
-8,450
| -2% | -$111K |
|
2642
PAR Technology
PAR
$770M
| $4.55M | ﹤0.01% |
147,890
-3,329
| -2% | -$91.1K |
|
2643
Ardelyx
ARDX
$1.01B
| $4.53M | ﹤0.01% |
604,160
+51,255
| +9% | +$311K |
|
|
EIGR
2644
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $4.52M | ﹤0.01% |
10,115
+167
| +2% | +$59.3K |
|
|
JCP
2645
DELISTED
J.C. Penney Company, Inc.
JCP
| $4.5M | ﹤0.01% |
4,020,358
+61,992
| +2% | +$65.9K |
|
|
PING
2646
DELISTED
Ping Identity Holding Corp.
PING
| $4.49M | ﹤0.01% |
184,751
+152,203
| +468% | +$2.91M |
|
2647
NN Inc
NNBR
$298M
| $4.49M | ﹤0.01% |
484,892
-14,964
| -3% | -$120K |
|
|
CBPO
2648
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $4.49M | ﹤0.01% |
38,542
-524
| -1% | -$60.7K |
|
2649
Kewaunee Scientific
KEQU
$105M
| $4.47M | ﹤0.01% |
332,230
-1,131
| -0.3% | -$17.7K |
|
|
ACBI
2650
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $4.47M | ﹤0.01% |
243,470
-13,457
| -5% | -$247K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.